Cargando…

The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series

INTRODUCTION: Stroke-like syndrome (SLS) is a rare subacute neurological complication of intrathecal or high-dose (≥500 mg) Methotrexate (MTX) administration. Its clinical features, evoking acute cerebral ischaemia with fluctuating course symptoms and a possible spontaneous resolution, have elicited...

Descripción completa

Detalles Bibliográficos
Autores principales: Santangelo, Andrea, Bartolini, Emanuele, Nuzzi, Giulia, Foiadelli, Thomas, Michev, Alexandre, Mina, Tommaso, Trambusti, Irene, Fichera, Valeria, Bonuccelli, Alice, Massimetti, Gabriele, Peroni, Diego G., De Marco, Emanuela, Coccoli, Luca, Luti, Laura, Bernasconi, Sayla, Nardi, Margherita, Menconi, Maria Cristina, Casazza, Gabriella, Pruna, Dario, Mura, Rosamaria, Marra, Chiara, Zama, Daniele, Striano, Pasquale, Cordelli, Duccio M., Battini, Roberta, Orsini, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226576/
https://www.ncbi.nlm.nih.gov/pubmed/35756920
http://dx.doi.org/10.3389/fneur.2022.920214
_version_ 1784733935038627840
author Santangelo, Andrea
Bartolini, Emanuele
Nuzzi, Giulia
Foiadelli, Thomas
Michev, Alexandre
Mina, Tommaso
Trambusti, Irene
Fichera, Valeria
Bonuccelli, Alice
Massimetti, Gabriele
Peroni, Diego G.
De Marco, Emanuela
Coccoli, Luca
Luti, Laura
Bernasconi, Sayla
Nardi, Margherita
Menconi, Maria Cristina
Casazza, Gabriella
Pruna, Dario
Mura, Rosamaria
Marra, Chiara
Zama, Daniele
Striano, Pasquale
Cordelli, Duccio M.
Battini, Roberta
Orsini, Alessandro
author_facet Santangelo, Andrea
Bartolini, Emanuele
Nuzzi, Giulia
Foiadelli, Thomas
Michev, Alexandre
Mina, Tommaso
Trambusti, Irene
Fichera, Valeria
Bonuccelli, Alice
Massimetti, Gabriele
Peroni, Diego G.
De Marco, Emanuela
Coccoli, Luca
Luti, Laura
Bernasconi, Sayla
Nardi, Margherita
Menconi, Maria Cristina
Casazza, Gabriella
Pruna, Dario
Mura, Rosamaria
Marra, Chiara
Zama, Daniele
Striano, Pasquale
Cordelli, Duccio M.
Battini, Roberta
Orsini, Alessandro
author_sort Santangelo, Andrea
collection PubMed
description INTRODUCTION: Stroke-like syndrome (SLS) is a rare subacute neurological complication of intrathecal or high-dose (≥500 mg) Methotrexate (MTX) administration. Its clinical features, evoking acute cerebral ischaemia with fluctuating course symptoms and a possible spontaneous resolution, have elicited interest among the scientific community. However, many issues are still open on the underlying pathogenesis, clinical, and therapeutic management and long-term outcome. MATERIALS AND METHODS: We retrospectively analyzed clinical, radiological and laboratory records of all patients diagnosed with SLS between 2011 and 2021 at 4 National referral centers for Pediatric Onco-Hematology. Patients with a latency period that was longer than 3 weeks between the last MTX administration of MTX and SLS onset were excluded from the analysis, as were those with unclear etiologies. We assessed symptom severity using a dedicated arbitrary scoring system. Eleven patients were included in the study. RESULTS: The underlying disease was acute lymphoblastic leukemia type B in 10/11 patients, while fibroblastic osteosarcoma was present in a single subject. The median age at diagnosis was 11 years (range 4–34), and 64% of the patients were women. Symptoms occurred after a mean of 9.45 days (± 0.75) since the last MTX administration and lasted between 1 and 96 h. Clinical features included hemiplegia and/or cranial nerves palsy, paraesthesia, movement or speech disorders, and seizure. All patients underwent neuroimaging studies (CT and/or MRI) and EEG. The scoring system revealed an average of 4.9 points (± 2.3), with a median of 5 points (maximum 20 points). We detected a linear correlation between the severity of the disease and age in male patients. CONCLUSIONS: SLS is a rare, well-characterized complication of MTX administration. Despite the small sample, we have been able to confirm some of the previous findings in literature. We also identified a linear correlation between age and severity of the disease, which could improve the future clinical management.
format Online
Article
Text
id pubmed-9226576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92265762022-06-25 The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series Santangelo, Andrea Bartolini, Emanuele Nuzzi, Giulia Foiadelli, Thomas Michev, Alexandre Mina, Tommaso Trambusti, Irene Fichera, Valeria Bonuccelli, Alice Massimetti, Gabriele Peroni, Diego G. De Marco, Emanuela Coccoli, Luca Luti, Laura Bernasconi, Sayla Nardi, Margherita Menconi, Maria Cristina Casazza, Gabriella Pruna, Dario Mura, Rosamaria Marra, Chiara Zama, Daniele Striano, Pasquale Cordelli, Duccio M. Battini, Roberta Orsini, Alessandro Front Neurol Neurology INTRODUCTION: Stroke-like syndrome (SLS) is a rare subacute neurological complication of intrathecal or high-dose (≥500 mg) Methotrexate (MTX) administration. Its clinical features, evoking acute cerebral ischaemia with fluctuating course symptoms and a possible spontaneous resolution, have elicited interest among the scientific community. However, many issues are still open on the underlying pathogenesis, clinical, and therapeutic management and long-term outcome. MATERIALS AND METHODS: We retrospectively analyzed clinical, radiological and laboratory records of all patients diagnosed with SLS between 2011 and 2021 at 4 National referral centers for Pediatric Onco-Hematology. Patients with a latency period that was longer than 3 weeks between the last MTX administration of MTX and SLS onset were excluded from the analysis, as were those with unclear etiologies. We assessed symptom severity using a dedicated arbitrary scoring system. Eleven patients were included in the study. RESULTS: The underlying disease was acute lymphoblastic leukemia type B in 10/11 patients, while fibroblastic osteosarcoma was present in a single subject. The median age at diagnosis was 11 years (range 4–34), and 64% of the patients were women. Symptoms occurred after a mean of 9.45 days (± 0.75) since the last MTX administration and lasted between 1 and 96 h. Clinical features included hemiplegia and/or cranial nerves palsy, paraesthesia, movement or speech disorders, and seizure. All patients underwent neuroimaging studies (CT and/or MRI) and EEG. The scoring system revealed an average of 4.9 points (± 2.3), with a median of 5 points (maximum 20 points). We detected a linear correlation between the severity of the disease and age in male patients. CONCLUSIONS: SLS is a rare, well-characterized complication of MTX administration. Despite the small sample, we have been able to confirm some of the previous findings in literature. We also identified a linear correlation between age and severity of the disease, which could improve the future clinical management. Frontiers Media S.A. 2022-06-10 /pmc/articles/PMC9226576/ /pubmed/35756920 http://dx.doi.org/10.3389/fneur.2022.920214 Text en Copyright © 2022 Santangelo, Bartolini, Nuzzi, Foiadelli, Michev, Mina, Trambusti, Fichera, Bonuccelli, Massimetti, Peroni, De Marco, Coccoli, Luti, Bernasconi, Nardi, Menconi, Casazza, Pruna, Mura, Marra, Zama, Striano, Cordelli, Battini and Orsini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Santangelo, Andrea
Bartolini, Emanuele
Nuzzi, Giulia
Foiadelli, Thomas
Michev, Alexandre
Mina, Tommaso
Trambusti, Irene
Fichera, Valeria
Bonuccelli, Alice
Massimetti, Gabriele
Peroni, Diego G.
De Marco, Emanuela
Coccoli, Luca
Luti, Laura
Bernasconi, Sayla
Nardi, Margherita
Menconi, Maria Cristina
Casazza, Gabriella
Pruna, Dario
Mura, Rosamaria
Marra, Chiara
Zama, Daniele
Striano, Pasquale
Cordelli, Duccio M.
Battini, Roberta
Orsini, Alessandro
The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title_full The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title_fullStr The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title_full_unstemmed The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title_short The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
title_sort clinical impact of methotrexate-induced stroke-like neurotoxicity in paediatric departments: an italian multi-centre case-series
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226576/
https://www.ncbi.nlm.nih.gov/pubmed/35756920
http://dx.doi.org/10.3389/fneur.2022.920214
work_keys_str_mv AT santangeloandrea theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bartoliniemanuele theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT nuzzigiulia theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT foiadellithomas theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT michevalexandre theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT minatommaso theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT trambustiirene theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT ficheravaleria theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bonuccellialice theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT massimettigabriele theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT peronidiegog theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT demarcoemanuela theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT coccoliluca theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT lutilaura theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bernasconisayla theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT nardimargherita theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT menconimariacristina theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT casazzagabriella theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT prunadario theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT murarosamaria theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT marrachiara theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT zamadaniele theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT strianopasquale theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT cordelliducciom theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT battiniroberta theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT orsinialessandro theclinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT santangeloandrea clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bartoliniemanuele clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT nuzzigiulia clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT foiadellithomas clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT michevalexandre clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT minatommaso clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT trambustiirene clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT ficheravaleria clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bonuccellialice clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT massimettigabriele clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT peronidiegog clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT demarcoemanuela clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT coccoliluca clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT lutilaura clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT bernasconisayla clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT nardimargherita clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT menconimariacristina clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT casazzagabriella clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT prunadario clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT murarosamaria clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT marrachiara clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT zamadaniele clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT strianopasquale clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT cordelliducciom clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT battiniroberta clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries
AT orsinialessandro clinicalimpactofmethotrexateinducedstrokelikeneurotoxicityinpaediatricdepartmentsanitalianmulticentrecaseseries